Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults
Description
CONCLUSIONS AND RELEVANCE: In this cohort study of older US adults, the mRNA-1273 vaccine was associated with a slightly lower risk of several adverse events compared with BNT162b2, possibly due to greater protection against COVID-19. Future research
